Clinical Pharmacokinetics and Pharmacodynamics¶
Rowland, M., & Tozer, T. N. (2011). Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications.
Cited by¶
9 citations across 9 artifacts.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Bioavailability
- Across a multi-stage path it is approximately the product of per-stage retention fractions.
This sourceStandard pharmacokinetics text defining bioavailability F as the fraction of an administered dose reaching systemic circulation in active form, F = AUC_oral/AUC_IV with IV defined as 100%, F ≈ f_a·f_g·f_h as the product of per-stage retentions, and the consequences for oral-versus-IV dose equivalence and high-extraction-ratio drugs.
- Across a multi-stage path it is approximately the product of per-stage retention fractions.
- Clearance Rate
- A kinetic regime: clearance is typically first-order, proportional to current stock and producing exponential decay with a definite half-life, or zero-order, a fixed maximum rate that saturates while excess accumulates, with mixed regimes in between.
This sourceStandard text on clearance, first-order versus zero-order (Michaelis–Menten) kinetics, half-life, steady state, and dose adjustment for organ impairment.
- A kinetic regime: clearance is typically first-order, proportional to current stock and producing exponential decay with a definite half-life, or zero-order, a fixed maximum rate that saturates while excess accumulates, with mixed regimes in between.
- Loading Dose
- In pharmacology, the origin, a drug with a long half-life is started with a single loading dose to reach therapeutic concentration in hours instead of days, after which ongoing doses balance clearance.
This sourceLoading dose = C_target x V_d and maintenance rate = C_target x CL under first-order one-compartment kinetics, with the exponential approach to steady state set by the elimination half-life and the overshoot hazard of an oversized bolus.
- In pharmacology, the origin, a drug with a long half-life is started with a single loading dose to reach therapeutic concentration in hours instead of days, after which ongoing doses balance clearance.
- PK/PD Modeling (Pharmacokinetics / Pharmacodynamics)
- PK/PD modeling is the coupled mathematical framework for characterizing what the body does to a drug (pharmacokinetics, PK — absorption, distribution, metabolism, excretion) and what the drug does to the body (pharmacodynamics, PD — the concentration-response relationship at the site of action), with the coupling providing a dose→concentration→effect pipeline that is the central quantitative apparatus of clinical pharmacology, as Rowland and Tozer (2010) develop in their canonical treatment of clinical pharmacokinetics and pharmacodynamics.
This sourceLippincott Williams & Wilkins. Standard pharmacokinetics text: develops compartment-model decay of drug plasma concentration as a signal-level phenomenon distinct from chronic system-level functional decline.
- PK/PD modeling is the coupled mathematical framework for characterizing what the body does to a drug (pharmacokinetics, PK — absorption, distribution, metabolism, excretion) and what the drug does to the body (pharmacodynamics, PD — the concentration-response relationship at the site of action), with the coupling providing a dose→concentration→effect pipeline that is the central quantitative apparatus of clinical pharmacology, as Rowland and Tozer (2010) develop in their canonical treatment of clinical pharmacokinetics and pharmacodynamics.
- Rate Limiting
- The token-bucket insight that a bucket admits bursts up to its size then averages to its refill rate transfers to pharmacology: a loading dose followed by maintenance dosing is the same shape, with bucket size as the loading dose, refill rate as the maintenance dose, and leakage as pharmacokinetic clearance.
This sourceStandard text on dose regimens: a loading dose rapidly fills the body's drug 'budget' and a maintenance dose replenishes it against clearance — the pharmacokinetic analogue of bucket size, refill rate, and leakage.
- The token-bucket insight that a bucket admits bursts up to its size then averages to its refill rate transfers to pharmacology: a loading dose followed by maintenance dosing is the same shape, with bucket size as the loading dose, refill rate as the maintenance dose, and leakage as pharmacokinetic clearance.
- Signal Decay and Fadeout
- A patient on a fixed antibiotic dose experiences signal decay (drug concentration diminishes, efficacy weakens) while the drug itself remains chemically unchanged; the system (the patient's body) is the environment in which the signal (drug molecules) decays, a clinical consequence Rowland and Tozer (2010) develop systematically through compartment-model pharmacokinetics.
This sourceLippincott Williams & Wilkins. Standard pharmacokinetics text: develops compartment-model decay of drug plasma concentration as a signal-level phenomenon distinct from chronic system-level functional decline.
- A patient on a fixed antibiotic dose experiences signal decay (drug concentration diminishes, efficacy weakens) while the drug itself remains chemically unchanged; the system (the patient's body) is the environment in which the signal (drug molecules) decays, a clinical consequence Rowland and Tozer (2010) develop systematically through compartment-model pharmacokinetics.
- Washout Failure
- A unit is held under condition \(A\), which induces a state \(s\) that, after \(A\) is removed, decays as \(s(t) = s_0 e^{-t/\tau}\) with half-life \(t_{1/2} = \tau \ln 2\).
This sourceStandard source for first-order (mono-exponential) elimination C(t)=C0 e^(-kt) with half-life t_{1/2}=ln 2 / k — the textbook decay identity used here.
- A unit is held under condition \(A\), which induces a state \(s\) that, after \(A\) is removed, decays as \(s(t) = s_0 e^{-t/\tau}\) with half-life \(t_{1/2} = \tau \ln 2\).
Domain-specific¶
- Elimination Rate Constant
- Volume of Distribution
- Listed in the references but not attached to a specific claim.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Links previously used in the corpus¶
Before the registry existed this work was also linked 3 other ways.
- https://search.worldcat.org/title/427509167 ×1
- https://shop.lww.com/p/9781496385048 ×1
- https://www.worldcat.org/title/clinical-pharmacokinetics-and-pharmacodynamics-concepts-and-applications/oclc/644836509 ×1
Registry ID ref:c19c31c41d52 · see in the full table